Acquisition Opportunity Taylors Pharmacy has been acquired by Revelation Pharma, supported by Osceola Capital, which may lead to expanded distribution needs, access to new markets, and potential integration projects for supply chain, IT systems, and regulatory compliance services.

Independent Specialty As a independently owned and operated compounding pharmacy with a state‑of‑the‑art lab, Taylors may seek advanced compounding ingredients, high‑quality APIs, and scalable CSP (custom pharmaceutical) solutions to support growing demand and veterinary compounding services.

Mid‑Market Focus Revenue in the 25–50 million range and a leaner team (11–50 employees) position Taylors as a target for mid‑market distributors and vendor partners who can offer competitive pricing, reliable supply, and scalable tech to support growth without the overhead of大型 enterprise implementations.

Technology Stack Fit Current tech usage with HubSpot, data tables, and web security features suggests opportunities to offer CRM, marketing automation, e‑commerce, or compliance analytics integrations that streamline order workflows, customer segmentation, and regulatory reporting.

Growth Synergies The presence of veterinary compounding and wholesale services indicates cross‑sell potential into veterinary clinics and independent pharmacies, as well as private label or contract manufacturing opportunities to broaden product offerings.